DGAP-News

Novavax to Host 2nd Annual Analyst and Investor Meeting

DGAP-News: Novavax, Inc.
Novavax to Host 2nd Annual Analyst and Investor Meeting

11.09.2014 / 23:17

---------------------------------------------------------------------

GAITHERSBURG, Md., 2014-09-11 23:17 CEST (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused
on the discovery, development and commercialization of recombinant nanoparticle
vaccines and adjuvants, announced that it will host its 2nd annual Analyst and
Investor Meeting to be held on Tuesday, September 23, 2014 from 9:00 a.m. -
11:00 a.m. (ET) in New York, NY.

Senior management will conduct a series of presentations to update analysts and
investors as to the company's recombinant nanoparticle vaccine technology, its
RSV program, and its influenza program.

For additional information and registration, please e-mail
[e-mail], or call 443-213-0506.

A live webcast link of the presentations will be available via the company
website at www.novavax.com under Investor Info/Events. Please allow extra time
prior to the webcast to visit the site and download the streaming media
software required to listen to the Internet broadcast. The event will be
archived on the company's website for 90 days.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating vaccines and vaccine adjuvants to address a broad range of infectious
diseases worldwide. Using innovative proprietary recombinant nanoparticle
vaccine technology, the company produces vaccine candidates to efficiently and
effectively respond to both known and newly emergent diseases.


Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Novavax, Inc.
240-268-2000
News Source: NASDAQ OMX



---------------------------------------------------------------------

11.09.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: Novavax, Inc.


United States
ISIN: US6700021040


End of News DGAP News-Service
---------------------------------------------------------------------
286746 11.09.2014